Dong-A's epirubicin wins COS certification
Published: 2006-07-14 06:57:00
Updated: 2006-07-14 06:57:00
Dong-A Pharm said its achieved epirubicin HCl has acquired a COS (Certification of Suitability of Monographs of the European Pharmacopoeia) certification from the European Directorate for the Quality Medicines on June 21.
Epirubicin HCl belongs to the general group of chemotherapy drugs known ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
